VitaNova Life Sciences (VNOV) Long-Term Deferred Tax (2018 - 2026)

VitaNova Life Sciences has disclosed Long-Term Deferred Tax across 9 years of filings, most recently posting $16038.0 for Q3 2026.

• Long-Term Deferred Tax for Q3 2026 came in at $16038.0, down 86.64% year-over-year; the trailing twelve-month figure through Jul 2026 was $16038.0 (down 86.64% YoY), and the FY2026 annual result was $16038.0, changed N/A from the prior year.
• Long-Term Deferred Tax for Q3 2026 stood at $16038.0, roughly flat from $16038.0 in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $156912.0 in Q4 2023 and bottomed at $8632.0 in Q4 2022.
• Average Long-Term Deferred Tax over 5 years is $72806.4, with a median of $72876.0 recorded in 2022.
• The widest annual swing landed in 2022, when Long-Term Deferred Tax plunged 89.45%; it then soared 1717.79% in 2023.
• Year by year, Long-Term Deferred Tax stood at $8632.0 in 2022, then surged by 1717.79% to $156912.0 in 2023, then sank by 49.73% to $78887.0 in 2024, then surged by 87.52% to $147929.0 in 2025, then sank by 89.16% to $16038.0 in 2026.
• The last three Long-Term Deferred Tax figures came in at $16038.0 (Q3 2026), $16038.0 (Q2 2026), and $98161.0 (Q1 2026), per Business Quant data.